On ECHEMI
Home > Drugs > Shandong Quangang Pharmaceutical Co., Ltd.
Shandong Quangang Pharmaceutical Co., Ltd.
  • Founded in:

    2001-04-29
  • Country:

    China China
  • Address:

    No. 225 Jiangshuiquan Road, Jinan City
  • Tax NO.:

    9137010272861438X3
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human interleukin-2 (Ⅰ) for injection
Recombinant human interleukin-2 (125Ser)
Name Description Content CAS NO. Registered Holders
Recombinant human interleukin-2 (125Ser)

This product shows biological activity of human natural IL-2, including increasing lymphocyte mitosis, proliferating cytotoxic T cells, natural killer cells and lymphokine-activated killer cells (LAK), and enhancing their killing activity. When the dosage of this product in the human body reaches a certain level, it will produce immune effects and induce the production of some cytokines such as tumor necrosis factor, IL-1 and gamma-interferon. This product has anti-viral, anti-tumor and immune enhancement effects.

More

This product shows biological activity of human natural IL-2, including increasing lymphocyte mitosis, proliferating cytotoxic T cells, natural killer cells and lymphokine-activated killer cells (LAK), and enhancing their killing activity. When the dosage of this product in the human body reaches a certain level, it will produce immune effects and induce the production of some cytokines such as tumor necrosis factor, IL-1 and gamma-interferon. This product has anti-viral, anti-tumor and immune enhancement effects.

0
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG?/FONTCSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG?/FONTCSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminally differentiated cells.

More

This product is human granulocyte colony stimulating factor (rhG?/FONTCSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG?/FONTCSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminally differentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.